A monoclonal antibody 1A6 to T-cell recognizes a common antigen expressed on lymphocytes from normal and leukemic patients, and inhibits NK cell activity

Hematological Oncology
H TogashiP I Terasaki

Abstract

A new monoclonal antibody (MAB), IA61gG2a, has been derived from Balb/c mice after immunization with T-cell chronic lymphocytic leukemia (T-CLL). This monoclonal antibody, 1A6 was tested on normal human peripheral blood cells, leukemia patients' cells and leukemia-lymphoma cell lines. The results demonstrated that this antibody reacts with normal human T and B cells, but not with erythrocytes, granulocytes or platelets. Further examinations showed 10/11 leukemic patient cell types were positive with 1A6. In contrast, many leukemia-lymphoma cell lines were negative (14/17), i.e. T and B leukemia lymphoma cell lines, non-T and non-B leukemia cell lines as examined by complement mediated cytotoxicity test and immunofluorescence test. Other prominent characteristics of 1A6 MAB have been demonstrated, which include inhibition of myeloid colony formation (CFU-C) and suppression of human natural killer cell cytotoxicity (NKCC). These results suggest that 1A6 is a common marker for normal T, B, NK cells and leukemic patients cells having T and B cell origin, but 1A6 antigen is not expressed on many leukemia lymphoma cell lines. Therefore, it could be useful for studying malignant transformation of lymphoid cells.

References

Feb 1, 1978·American Journal of Clinical Pathology·P I TerasakiY Iwaki
Jan 1, 1987·International Journal of Immunopharmacology·M GhoneumL J Alfred
Oct 1, 1973·European Journal of Immunology·M H JuliusL A Herzenberg
Apr 1, 1981·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S M HsuH Fanger
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·W Newman
Jul 1, 1983·American Journal of Clinical Pathology·S M HsuE S Jaffe
Jan 1, 1981·The Journal of Experimental Medicine·S PoppemaS F Schlossman
Jan 1, 1983·The Journal of Experimental Medicine·T AboC M Balch
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Oct 1, 1980·The Journal of Experimental Medicine·M B OmaryH A Battifora

Citations

Nov 8, 2005·Journal of Immunological Methods·Rebecca J MorrisEddie C Y Wang
May 19, 2007·American Journal of Clinical Pathology·William G Morice

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.